Clinic-based scope for bladder cancer follow-up
Part of Cancer, Kidney & urinary clinical trials.
This trial tests if a procedure done in the clinic, without general anesthesia, can safely check the upper urinary tract after kidney-sparing surgery for urothelial cancer. It may reduce the need for hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had kidney-sparing surgery for upper urinary tract cancer in the past
- You are not allergic to lidocaine jelly used in the urethra
- You are not taking blood thinners that can't be stopped before the procedure
- You do not have any abnormal structures in the upper urinary tract on the side being examined
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking how well a flexible ureteroscope (a thin, flexible tube with a camera) finds any return of cancer in the upper urinary tract after surgery that saved the kidney. It may help detect problems early without needing more invasive tests.
This trial compares removing the kidney and ureter alone versus also removing nearby lymph nodes for high-risk upper tract urothelial cancer. It aims to see if the extra step helps improve outcomes.
This trial is testing a kidney-sparing treatment approach for people with high-risk cancer in the kidney or ureter that has not spread. It aims to control the cancer while saving as much of the kidney's function as possible.
This study tests whether a simple urine test can accurately identify cancer in the bladder, ureters (tubes between kidneys and bladder), or renal pelvis (part of the kidney). You would provide urine samples before your planned surgery, and researchers will compare the urine test results to your actual tissue diagnosis after surgery.
This trial tests a new, disposable flexible camera (ureteroscope) to safely check for or monitor upper urinary tract cancer in an office setting without putting you to sleep. The goal is to see if patients can tolerate this procedure comfortably while awake.
This study looks at how well patients do when they have kidney-sparing treatment (instead of complete kidney removal) for upper tract urothelial carcinoma. It helps doctors understand which patients can safely avoid losing their kidney.
Hear when a new Upper Tract Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.